Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021


HomeParagonix Technologies IncParagonix Technologies Launches New OPTION On-Demand Preservation Services Network

Paragonix Technologies Launches New OPTION On-Demand Preservation Services Network

Paragonix Technologies

Paragonix Technologies announces the launch of its new OPTION On-Demand Preservation Services Network in the United States. OPTION is an around-the-clock rapid deployment service designed to better serve the transplant community and improve efficiencies in donor organ procurement and recovery.

The company reports the first phase of the OPTION program has launched, including the establishment of a nationwide forward deployment of distributed inventory at responsive depots to ensure transplant surgeons have access to advanced hypothermic preservation technologies.

Due to increased product demands, and the challenging logistics associated with recovering, preserving and transporting donor organs, regularly in only a few hours and often in the middle of the night, Paragonix Technologies is launching this just-in-time service to ensure 24/7 availability of Paragonix organ preservation products.

In addition, with a rise in “local procurement,” an increasingly common situation where a transplant team local to the donor recovers the organ(s) and sends them to the recipient hospital transplant team, the need has increased for distributed inventory and a more rapidly deployed product. A recent recovery in Alaska required the securing of a locally inventoried Paragonix organ preservation device in under a few hours, to support the transport of a donor organ to the east coast. By increasing access to regionally available inventory, Paragonix will support logistically challenging procurements and improve the efficiency of the organ donation system.

“We are proud to offer the OPTION in collaboration with top logistics providers across the country,” says Garrett Riddle, VP Manufacturing at Paragonix Technologies. “Whether it is an outreach from a U.S. transplant center or Organ Procurement Organization, our team is now able to rapidly deploy Paragonix devices to the site of organ donation 24/7/365.”
“The donation and transplant teams involved in donor organ procurements are working tirelessly around the clock to serve donor families and transplant recipients. While we have offered 24/7 clinical and technical support since market entry, we can now supercharge customer support with our OPTION program,” said Lisa Anderson, Ph.D., President & CEO at Paragonix Technologies, Inc. “This new offering will increase our coverage for any type of case that arises.”

OPTION is just the latest element in a strategy to provide advanced services to improve transplant efficiencies. Paragonix has already launched a digital platform to enhance transplant team coordination and data visibility. In future phases the company will be further expanding offerings to continue improve the efficiency and effectiveness of transplant services.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy